Dr. Matthew D. Cheney
Claim this profileMaine Medical Center- Scarborough Campus
Studies Cancer
Studies Breast Cancer
20 reported clinical trials
58 drugs studied
Area of expertise
1Cancer
Stage IV
Stage I
Stage II
2Breast Cancer
Stage II
Stage I
HER2 negative
Affiliated Hospitals
Clinical Trials Matthew D. Cheney is currently running
Stereotactic Radiation + Immunotherapy
for Kidney Cancer
This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherapy improves outcomes in patients with renal cell cancer that is not recommended for surgery and has spread to other places in the body (metastatic). Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses of radiation over a shorter period and cause less damage to normal tissue. Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, avelumab, and pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib, cabozantinib, and lenvatinib are in a class of medications called antiangiogenic agents. They work by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving SABR in combination with standard of care immunotherapy may help shrink or stabilize the cancer in patients with renal cell cancer.
Recruiting1 award Phase 221 criteria
Chemotherapy + Radiotherapy
for Esophageal and Gastric Cancer
This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy x-rays, gamma rays, or protons to kill tumor cells and shrink tumors. Drugs used in usual chemotherapy, such as leucovorin, 5-fluorouracil, oxaliplatin, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Adding radiotherapy to the usual chemotherapy may work better compared to the usual chemotherapy alone in treating patients with esophageal and gastric cancer.
Recruiting2 awards Phase 320 criteria
More about Matthew D. Cheney
Clinical Trial Related2 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Matthew D. Cheney has experience with
- Radiation Therapy
- Intensity-Modulated Radiation Therapy
- Cisplatin
- Bicalutamide
- Fluorouracil
- Nivolumab
Breakdown of trials Matthew D. Cheney has run
Cancer
Breast Cancer
Prostate Adenocarcinoma
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew D. Cheney specialize in?
Matthew D. Cheney focuses on Cancer and Breast Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage I.
Is Matthew D. Cheney currently recruiting for clinical trials?
Yes, Matthew D. Cheney is currently recruiting for 10 clinical trials in Scarborough Maine. If you're interested in participating, you should apply.
Are there any treatments that Matthew D. Cheney has studied deeply?
Yes, Matthew D. Cheney has studied treatments such as Radiation Therapy, Intensity-Modulated Radiation Therapy, Cisplatin.
What is the best way to schedule an appointment with Matthew D. Cheney?
Apply for one of the trials that Matthew D. Cheney is conducting.
What is the office address of Matthew D. Cheney?
The office of Matthew D. Cheney is located at: Maine Medical Center- Scarborough Campus, Scarborough, Maine 04074 United States. This is the address for their practice at the Maine Medical Center- Scarborough Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.